Update on Transvaginal Mesh Litigation

We are at the forefront of Chicago law firms representing women injured by surgical mesh, a product used to treat pelvic organ prolapsed (POP) and Stress Urinary Incontinence (SUI). Made of woven polyester, polypropylene or other materials, the mesh is permanently implanted in the vaginal wall.

Thousands of women have been seriously injured by implantation of surgical mesh to relieve and support weakened pelvic muscles. As early as 2008, the U.S. Food and Drug Administration (FDA) issued a public health notice concerning serious complications associated with use of surgical mesh including vaginal erosion, pelvic organ and vascular perforation, neurologic damage and pain. Yet these devices remain in use.

In February of 2013, a New Jersey jury delivered the first verdict in more than 2,000 lawsuits filed against manufacturers concerning surgical mesh in the United States. Linda Gross, a 47-year old hospice nurse from South Dakota received the Gynecare Prolift mesh implant in 2006 as a remedy to pelvic prolapse. Manufactured by Ethicon, a subsidiary of Johnson and Johnson (JNJ) based in New Jersey, Ms. Gross experienced no relief from the product, and instead faced 18 additional operations to address pain and internal damage as the mesh eroded.

In her product liability lawsuit, the jury awarded Ms. Gross $3.35 million in compensatory damages and $7.8 million in punitive damages. Although the jury did not find the Ethicon product was defective, it found the company provided insufficient warning prior to use of the device by her surgeon and misrepresented risks of the product.

Although Gynecare Prolift was removed from the market in 2012, Ms. Gross must self-catheterize simply to urinate because of the damage done to her by the mesh. This first verdict gives hope to women across the country injured by mesh products.

If you have suffered harm from a transvaginal mesh implant, talk to us about your injury.